nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—ABCG2—Fluorouracil—head and neck cancer	0.168	0.232	CbGbCtD
Venlafaxine—CYP2D6—Hydroxyurea—head and neck cancer	0.149	0.206	CbGbCtD
Venlafaxine—ABCG2—Docetaxel—head and neck cancer	0.128	0.177	CbGbCtD
Venlafaxine—CYP2C9—Fluorouracil—head and neck cancer	0.0624	0.0861	CbGbCtD
Venlafaxine—ABCB1—Vinblastine—head and neck cancer	0.0561	0.0774	CbGbCtD
Venlafaxine—CYP2D6—Vinblastine—head and neck cancer	0.0529	0.073	CbGbCtD
Venlafaxine—ABCB1—Docetaxel—head and neck cancer	0.0462	0.0638	CbGbCtD
Venlafaxine—CYP3A4—Vinblastine—head and neck cancer	0.0336	0.0464	CbGbCtD
Venlafaxine—CYP3A4—Docetaxel—head and neck cancer	0.0277	0.0382	CbGbCtD
Venlafaxine—Neutropenia—Hydroxyurea—head and neck cancer	0.001	0.00391	CcSEcCtD
Venlafaxine—Agranulocytosis—Vinblastine—head and neck cancer	0.000976	0.00382	CcSEcCtD
Venlafaxine—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.000974	0.00381	CcSEcCtD
Venlafaxine—Weight increased—Hydroxyurea—head and neck cancer	0.000973	0.00381	CcSEcCtD
Venlafaxine—Oliguria—Docetaxel—head and neck cancer	0.000961	0.00376	CcSEcCtD
Venlafaxine—Drug interaction—Docetaxel—head and neck cancer	0.000955	0.00374	CcSEcCtD
Venlafaxine—Amnesia—Fluorouracil—head and neck cancer	0.000948	0.00371	CcSEcCtD
Venlafaxine—Haemoglobin—Vinblastine—head and neck cancer	0.000943	0.00369	CcSEcCtD
Venlafaxine—Haemorrhage—Vinblastine—head and neck cancer	0.000939	0.00367	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000935	0.00366	CcSEcCtD
Venlafaxine—Hypoaesthesia—Vinblastine—head and neck cancer	0.000934	0.00366	CcSEcCtD
Venlafaxine—Dermatitis bullous—Fluorouracil—head and neck cancer	0.000932	0.00365	CcSEcCtD
Venlafaxine—Pharyngitis—Vinblastine—head and neck cancer	0.000931	0.00365	CcSEcCtD
Venlafaxine—Stomatitis—Hydroxyurea—head and neck cancer	0.000929	0.00364	CcSEcCtD
Venlafaxine—Bone pain—Docetaxel—head and neck cancer	0.000924	0.00362	CcSEcCtD
Venlafaxine—Respiratory failure—Docetaxel—head and neck cancer	0.000902	0.00353	CcSEcCtD
Venlafaxine—Osteoarthritis—Fluorouracil—head and neck cancer	0.000891	0.00349	CcSEcCtD
Venlafaxine—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.000891	0.00349	CcSEcCtD
Venlafaxine—Blood pressure increased—Docetaxel—head and neck cancer	0.000886	0.00347	CcSEcCtD
Venlafaxine—Pulmonary embolism—Docetaxel—head and neck cancer	0.000886	0.00347	CcSEcCtD
Venlafaxine—Hepatocellular injury—Docetaxel—head and neck cancer	0.000886	0.00347	CcSEcCtD
Venlafaxine—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.000886	0.00347	CcSEcCtD
Venlafaxine—Haemoglobin—Hydroxyurea—head and neck cancer	0.00086	0.00337	CcSEcCtD
Venlafaxine—Influenza like illness—Docetaxel—head and neck cancer	0.00086	0.00337	CcSEcCtD
Venlafaxine—Haemorrhage—Hydroxyurea—head and neck cancer	0.000856	0.00335	CcSEcCtD
Venlafaxine—Hallucination—Hydroxyurea—head and neck cancer	0.000852	0.00333	CcSEcCtD
Venlafaxine—Colitis—Docetaxel—head and neck cancer	0.00085	0.00333	CcSEcCtD
Venlafaxine—Irritability—Fluorouracil—head and neck cancer	0.00085	0.00333	CcSEcCtD
Venlafaxine—Cardiac arrest—Fluorouracil—head and neck cancer	0.000847	0.00332	CcSEcCtD
Venlafaxine—Candida infection—Docetaxel—head and neck cancer	0.000845	0.00331	CcSEcCtD
Venlafaxine—Ataxia—Fluorouracil—head and neck cancer	0.000837	0.00328	CcSEcCtD
Venlafaxine—Neuropathy—Docetaxel—head and neck cancer	0.000831	0.00325	CcSEcCtD
Venlafaxine—Alopecia—Vinblastine—head and neck cancer	0.000829	0.00325	CcSEcCtD
Venlafaxine—Dry skin—Fluorouracil—head and neck cancer	0.000816	0.0032	CcSEcCtD
Venlafaxine—Oesophagitis—Docetaxel—head and neck cancer	0.000809	0.00317	CcSEcCtD
Venlafaxine—Muscular weakness—Fluorouracil—head and neck cancer	0.000785	0.00307	CcSEcCtD
Venlafaxine—Dysphagia—Fluorouracil—head and neck cancer	0.00077	0.00301	CcSEcCtD
Venlafaxine—Chills—Hydroxyurea—head and neck cancer	0.000768	0.00301	CcSEcCtD
Venlafaxine—Eosinophilia—Fluorouracil—head and neck cancer	0.000762	0.00298	CcSEcCtD
Venlafaxine—Ill-defined disorder—Vinblastine—head and neck cancer	0.000758	0.00297	CcSEcCtD
Venlafaxine—Alopecia—Hydroxyurea—head and neck cancer	0.000756	0.00296	CcSEcCtD
Venlafaxine—Anaemia—Vinblastine—head and neck cancer	0.000755	0.00296	CcSEcCtD
Venlafaxine—Angina pectoris—Fluorouracil—head and neck cancer	0.00075	0.00294	CcSEcCtD
Venlafaxine—Erythema—Hydroxyurea—head and neck cancer	0.000745	0.00292	CcSEcCtD
Venlafaxine—Thrombophlebitis—Docetaxel—head and neck cancer	0.000743	0.00291	CcSEcCtD
Venlafaxine—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000739	0.00289	CcSEcCtD
Venlafaxine—Malaise—Vinblastine—head and neck cancer	0.000737	0.00288	CcSEcCtD
Venlafaxine—Vertigo—Vinblastine—head and neck cancer	0.000734	0.00287	CcSEcCtD
Venlafaxine—Leukopenia—Vinblastine—head and neck cancer	0.000731	0.00286	CcSEcCtD
Venlafaxine—Pancytopenia—Fluorouracil—head and neck cancer	0.000731	0.00286	CcSEcCtD
Venlafaxine—Deafness—Docetaxel—head and neck cancer	0.000719	0.00281	CcSEcCtD
Venlafaxine—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000715	0.0028	CcSEcCtD
Venlafaxine—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000709	0.00277	CcSEcCtD
Venlafaxine—Convulsion—Vinblastine—head and neck cancer	0.000708	0.00277	CcSEcCtD
Venlafaxine—Hypertension—Vinblastine—head and neck cancer	0.000705	0.00276	CcSEcCtD
Venlafaxine—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000703	0.00275	CcSEcCtD
Venlafaxine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000691	0.00271	CcSEcCtD
Venlafaxine—Pneumonia—Fluorouracil—head and neck cancer	0.00069	0.0027	CcSEcCtD
Venlafaxine—Anaemia—Hydroxyurea—head and neck cancer	0.000689	0.0027	CcSEcCtD
Venlafaxine—Discomfort—Vinblastine—head and neck cancer	0.000687	0.00269	CcSEcCtD
Venlafaxine—Hot flush—Docetaxel—head and neck cancer	0.000687	0.00269	CcSEcCtD
Venlafaxine—Menopausal symptoms—Docetaxel—head and neck cancer	0.000681	0.00267	CcSEcCtD
Venlafaxine—Atrial fibrillation—Docetaxel—head and neck cancer	0.000678	0.00266	CcSEcCtD
Venlafaxine—Visual disturbance—Docetaxel—head and neck cancer	0.000678	0.00266	CcSEcCtD
Venlafaxine—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000677	0.00265	CcSEcCtD
Venlafaxine—Renal impairment—Docetaxel—head and neck cancer	0.000675	0.00264	CcSEcCtD
Venlafaxine—Myocardial infarction—Fluorouracil—head and neck cancer	0.000673	0.00263	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000673	0.00263	CcSEcCtD
Venlafaxine—Dermatitis bullous—Docetaxel—head and neck cancer	0.000673	0.00263	CcSEcCtD
Venlafaxine—Malaise—Hydroxyurea—head and neck cancer	0.000672	0.00263	CcSEcCtD
Venlafaxine—Stomatitis—Fluorouracil—head and neck cancer	0.000669	0.00262	CcSEcCtD
Venlafaxine—Conjunctivitis—Fluorouracil—head and neck cancer	0.000667	0.00261	CcSEcCtD
Venlafaxine—Leukopenia—Hydroxyurea—head and neck cancer	0.000667	0.00261	CcSEcCtD
Venlafaxine—Thrombocytopenia—Vinblastine—head and neck cancer	0.000653	0.00256	CcSEcCtD
Venlafaxine—Epistaxis—Fluorouracil—head and neck cancer	0.000647	0.00253	CcSEcCtD
Venlafaxine—Convulsion—Hydroxyurea—head and neck cancer	0.000646	0.00253	CcSEcCtD
Venlafaxine—Hyponatraemia—Docetaxel—head and neck cancer	0.000645	0.00253	CcSEcCtD
Venlafaxine—Sinusitis—Fluorouracil—head and neck cancer	0.000644	0.00252	CcSEcCtD
Venlafaxine—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000643	0.00252	CcSEcCtD
Venlafaxine—Agranulocytosis—Fluorouracil—head and neck cancer	0.00064	0.00251	CcSEcCtD
Venlafaxine—Anorexia—Vinblastine—head and neck cancer	0.000636	0.00249	CcSEcCtD
Venlafaxine—Migraine—Docetaxel—head and neck cancer	0.000633	0.00248	CcSEcCtD
Venlafaxine—Discomfort—Hydroxyurea—head and neck cancer	0.000627	0.00245	CcSEcCtD
Venlafaxine—Haemoglobin—Fluorouracil—head and neck cancer	0.000619	0.00242	CcSEcCtD
Venlafaxine—Rhinitis—Fluorouracil—head and neck cancer	0.000618	0.00242	CcSEcCtD
Venlafaxine—Haemorrhage—Fluorouracil—head and neck cancer	0.000616	0.00241	CcSEcCtD
Venlafaxine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000613	0.0024	CcSEcCtD
Venlafaxine—Pharyngitis—Fluorouracil—head and neck cancer	0.000611	0.00239	CcSEcCtD
Venlafaxine—Oedema—Hydroxyurea—head and neck cancer	0.000608	0.00238	CcSEcCtD
Venlafaxine—Ataxia—Docetaxel—head and neck cancer	0.000604	0.00237	CcSEcCtD
Venlafaxine—Infection—Hydroxyurea—head and neck cancer	0.000604	0.00237	CcSEcCtD
Venlafaxine—Paraesthesia—Vinblastine—head and neck cancer	0.000599	0.00234	CcSEcCtD
Venlafaxine—Dehydration—Docetaxel—head and neck cancer	0.000598	0.00234	CcSEcCtD
Venlafaxine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000595	0.00233	CcSEcCtD
Venlafaxine—Liver function test abnormal—Docetaxel—head and neck cancer	0.000593	0.00232	CcSEcCtD
Venlafaxine—Dry skin—Docetaxel—head and neck cancer	0.000589	0.00231	CcSEcCtD
Venlafaxine—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000587	0.0023	CcSEcCtD
Venlafaxine—Anorexia—Hydroxyurea—head and neck cancer	0.00058	0.00227	CcSEcCtD
Venlafaxine—Decreased appetite—Vinblastine—head and neck cancer	0.00058	0.00227	CcSEcCtD
Venlafaxine—Cramp muscle—Docetaxel—head and neck cancer	0.000579	0.00227	CcSEcCtD
Venlafaxine—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000579	0.00227	CcSEcCtD
Venlafaxine—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000579	0.00227	CcSEcCtD
Venlafaxine—Constipation—Vinblastine—head and neck cancer	0.00057	0.00223	CcSEcCtD
Venlafaxine—Pain—Vinblastine—head and neck cancer	0.00057	0.00223	CcSEcCtD
Venlafaxine—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000567	0.00222	CcSEcCtD
Venlafaxine—Dysphagia—Docetaxel—head and neck cancer	0.000556	0.00217	CcSEcCtD
Venlafaxine—Arrhythmia—Fluorouracil—head and neck cancer	0.00055	0.00215	CcSEcCtD
Venlafaxine—Feeling abnormal—Vinblastine—head and neck cancer	0.000549	0.00215	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000545	0.00213	CcSEcCtD
Venlafaxine—Alopecia—Fluorouracil—head and neck cancer	0.000544	0.00213	CcSEcCtD
Venlafaxine—Dyspnoea—Hydroxyurea—head and neck cancer	0.000542	0.00212	CcSEcCtD
Venlafaxine—Angina pectoris—Docetaxel—head and neck cancer	0.000541	0.00212	CcSEcCtD
Venlafaxine—Somnolence—Hydroxyurea—head and neck cancer	0.000541	0.00212	CcSEcCtD
Venlafaxine—Erythema—Fluorouracil—head and neck cancer	0.000536	0.0021	CcSEcCtD
Venlafaxine—Dyspepsia—Hydroxyurea—head and neck cancer	0.000535	0.0021	CcSEcCtD
Venlafaxine—Decreased appetite—Hydroxyurea—head and neck cancer	0.000529	0.00207	CcSEcCtD
Venlafaxine—Pancytopenia—Docetaxel—head and neck cancer	0.000528	0.00207	CcSEcCtD
Venlafaxine—Abdominal pain—Vinblastine—head and neck cancer	0.000527	0.00206	CcSEcCtD
Venlafaxine—Fatigue—Hydroxyurea—head and neck cancer	0.000524	0.00205	CcSEcCtD
Venlafaxine—Pain—Hydroxyurea—head and neck cancer	0.00052	0.00204	CcSEcCtD
Venlafaxine—Constipation—Hydroxyurea—head and neck cancer	0.00052	0.00204	CcSEcCtD
Venlafaxine—Neutropenia—Docetaxel—head and neck cancer	0.000519	0.00203	CcSEcCtD
Venlafaxine—Weight increased—Docetaxel—head and neck cancer	0.000506	0.00198	CcSEcCtD
Venlafaxine—Vision blurred—Fluorouracil—head and neck cancer	0.000505	0.00198	CcSEcCtD
Venlafaxine—Weight decreased—Docetaxel—head and neck cancer	0.000503	0.00197	CcSEcCtD
Venlafaxine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000501	0.00196	CcSEcCtD
Venlafaxine—Pneumonia—Docetaxel—head and neck cancer	0.000498	0.00195	CcSEcCtD
Venlafaxine—Anaemia—Fluorouracil—head and neck cancer	0.000496	0.00194	CcSEcCtD
Venlafaxine—Hypersensitivity—Vinblastine—head and neck cancer	0.000491	0.00192	CcSEcCtD
Venlafaxine—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000491	0.00192	CcSEcCtD
Venlafaxine—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000488	0.00191	CcSEcCtD
Venlafaxine—Renal failure—Docetaxel—head and neck cancer	0.000487	0.00191	CcSEcCtD
Venlafaxine—Myocardial infarction—Docetaxel—head and neck cancer	0.000486	0.0019	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000486	0.0019	CcSEcCtD
Venlafaxine—Stomatitis—Docetaxel—head and neck cancer	0.000483	0.00189	CcSEcCtD
Venlafaxine—Jaundice—Docetaxel—head and neck cancer	0.000483	0.00189	CcSEcCtD
Venlafaxine—Conjunctivitis—Docetaxel—head and neck cancer	0.000481	0.00188	CcSEcCtD
Venlafaxine—Body temperature increased—Hydroxyurea—head and neck cancer	0.000481	0.00188	CcSEcCtD
Venlafaxine—Leukopenia—Fluorouracil—head and neck cancer	0.00048	0.00188	CcSEcCtD
Venlafaxine—Asthenia—Vinblastine—head and neck cancer	0.000478	0.00187	CcSEcCtD
Venlafaxine—Epistaxis—Docetaxel—head and neck cancer	0.000467	0.00183	CcSEcCtD
Venlafaxine—Convulsion—Fluorouracil—head and neck cancer	0.000465	0.00182	CcSEcCtD
Venlafaxine—Agranulocytosis—Docetaxel—head and neck cancer	0.000462	0.00181	CcSEcCtD
Venlafaxine—Myalgia—Fluorouracil—head and neck cancer	0.000457	0.00179	CcSEcCtD
Venlafaxine—Chest pain—Fluorouracil—head and neck cancer	0.000457	0.00179	CcSEcCtD
Venlafaxine—Diarrhoea—Vinblastine—head and neck cancer	0.000456	0.00179	CcSEcCtD
Venlafaxine—Discomfort—Fluorouracil—head and neck cancer	0.000451	0.00177	CcSEcCtD
Venlafaxine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000448	0.00175	CcSEcCtD
Venlafaxine—Haemoglobin—Docetaxel—head and neck cancer	0.000447	0.00175	CcSEcCtD
Venlafaxine—Rhinitis—Docetaxel—head and neck cancer	0.000446	0.00175	CcSEcCtD
Venlafaxine—Haemorrhage—Docetaxel—head and neck cancer	0.000445	0.00174	CcSEcCtD
Venlafaxine—Hepatitis—Docetaxel—head and neck cancer	0.000445	0.00174	CcSEcCtD
Venlafaxine—Hypoaesthesia—Docetaxel—head and neck cancer	0.000442	0.00173	CcSEcCtD
Venlafaxine—Confusional state—Fluorouracil—head and neck cancer	0.000441	0.00173	CcSEcCtD
Venlafaxine—Pharyngitis—Docetaxel—head and neck cancer	0.000441	0.00173	CcSEcCtD
Venlafaxine—Dizziness—Vinblastine—head and neck cancer	0.000441	0.00173	CcSEcCtD
Venlafaxine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000438	0.00171	CcSEcCtD
Venlafaxine—Oedema—Fluorouracil—head and neck cancer	0.000438	0.00171	CcSEcCtD
Venlafaxine—Asthenia—Hydroxyurea—head and neck cancer	0.000436	0.00171	CcSEcCtD
Venlafaxine—Infection—Fluorouracil—head and neck cancer	0.000435	0.0017	CcSEcCtD
Venlafaxine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000429	0.00168	CcSEcCtD
Venlafaxine—Visual impairment—Docetaxel—head and neck cancer	0.000429	0.00168	CcSEcCtD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.000428	0.0211	CbGpPWpGaD
Venlafaxine—Tachycardia—Fluorouracil—head and neck cancer	0.000427	0.00167	CcSEcCtD
Venlafaxine—Vomiting—Vinblastine—head and neck cancer	0.000424	0.00166	CcSEcCtD
Venlafaxine—Erythema multiforme—Docetaxel—head and neck cancer	0.00042	0.00165	CcSEcCtD
Venlafaxine—Headache—Vinblastine—head and neck cancer	0.000418	0.00164	CcSEcCtD
Venlafaxine—Anorexia—Fluorouracil—head and neck cancer	0.000417	0.00163	CcSEcCtD
Venlafaxine—Diarrhoea—Hydroxyurea—head and neck cancer	0.000416	0.00163	CcSEcCtD
Venlafaxine—Flushing—Docetaxel—head and neck cancer	0.000413	0.00162	CcSEcCtD
Venlafaxine—Cardiac disorder—Docetaxel—head and neck cancer	0.000413	0.00162	CcSEcCtD
Venlafaxine—Hypotension—Fluorouracil—head and neck cancer	0.000409	0.0016	CcSEcCtD
Venlafaxine—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000404	0.0199	CbGpPWpGaD
Venlafaxine—Dizziness—Hydroxyurea—head and neck cancer	0.000402	0.00157	CcSEcCtD
Venlafaxine—Chills—Docetaxel—head and neck cancer	0.000399	0.00156	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000399	0.00156	CcSEcCtD
Venlafaxine—Arrhythmia—Docetaxel—head and neck cancer	0.000397	0.00156	CcSEcCtD
Venlafaxine—Nausea—Vinblastine—head and neck cancer	0.000396	0.00155	CcSEcCtD
Venlafaxine—Insomnia—Fluorouracil—head and neck cancer	0.000396	0.00155	CcSEcCtD
Venlafaxine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000396	0.0195	CbGpPWpGaD
Venlafaxine—Paraesthesia—Fluorouracil—head and neck cancer	0.000393	0.00154	CcSEcCtD
Venlafaxine—Alopecia—Docetaxel—head and neck cancer	0.000393	0.00154	CcSEcCtD
Venlafaxine—Dyspnoea—Fluorouracil—head and neck cancer	0.00039	0.00153	CcSEcCtD
Venlafaxine—Somnolence—Fluorouracil—head and neck cancer	0.000389	0.00152	CcSEcCtD
Venlafaxine—Erythema—Docetaxel—head and neck cancer	0.000387	0.00152	CcSEcCtD
Venlafaxine—Vomiting—Hydroxyurea—head and neck cancer	0.000387	0.00151	CcSEcCtD
Venlafaxine—Dyspepsia—Fluorouracil—head and neck cancer	0.000385	0.00151	CcSEcCtD
Venlafaxine—Rash—Hydroxyurea—head and neck cancer	0.000383	0.0015	CcSEcCtD
Venlafaxine—Dermatitis—Hydroxyurea—head and neck cancer	0.000383	0.0015	CcSEcCtD
Venlafaxine—Headache—Hydroxyurea—head and neck cancer	0.000381	0.00149	CcSEcCtD
Venlafaxine—Decreased appetite—Fluorouracil—head and neck cancer	0.00038	0.00149	CcSEcCtD
Venlafaxine—Dysgeusia—Docetaxel—head and neck cancer	0.000379	0.00148	CcSEcCtD
Venlafaxine—ABCG2—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.000377	0.0186	CbGpPWpGaD
Venlafaxine—Back pain—Docetaxel—head and neck cancer	0.000374	0.00147	CcSEcCtD
Venlafaxine—Pain—Fluorouracil—head and neck cancer	0.000374	0.00147	CcSEcCtD
Venlafaxine—Muscle spasms—Docetaxel—head and neck cancer	0.000372	0.00146	CcSEcCtD
Venlafaxine—Nausea—Hydroxyurea—head and neck cancer	0.000361	0.00141	CcSEcCtD
Venlafaxine—Feeling abnormal—Fluorouracil—head and neck cancer	0.000361	0.00141	CcSEcCtD
Venlafaxine—Anaemia—Docetaxel—head and neck cancer	0.000358	0.0014	CcSEcCtD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.000353	0.0174	CbGpPWpGaD
Venlafaxine—Urticaria—Fluorouracil—head and neck cancer	0.000348	0.00136	CcSEcCtD
Venlafaxine—Syncope—Docetaxel—head and neck cancer	0.000347	0.00136	CcSEcCtD
Venlafaxine—Leukopenia—Docetaxel—head and neck cancer	0.000346	0.00136	CcSEcCtD
Venlafaxine—Body temperature increased—Fluorouracil—head and neck cancer	0.000346	0.00135	CcSEcCtD
Venlafaxine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000344	0.017	CbGpPWpGaD
Venlafaxine—Palpitations—Docetaxel—head and neck cancer	0.000342	0.00134	CcSEcCtD
Venlafaxine—Loss of consciousness—Docetaxel—head and neck cancer	0.00034	0.00133	CcSEcCtD
Venlafaxine—Cough—Docetaxel—head and neck cancer	0.000338	0.00132	CcSEcCtD
Venlafaxine—Convulsion—Docetaxel—head and neck cancer	0.000335	0.00131	CcSEcCtD
Venlafaxine—Hypertension—Docetaxel—head and neck cancer	0.000334	0.00131	CcSEcCtD
Venlafaxine—Myalgia—Docetaxel—head and neck cancer	0.00033	0.00129	CcSEcCtD
Venlafaxine—Chest pain—Docetaxel—head and neck cancer	0.00033	0.00129	CcSEcCtD
Venlafaxine—Arthralgia—Docetaxel—head and neck cancer	0.00033	0.00129	CcSEcCtD
Venlafaxine—NPY1R—GPCR ligand binding—KISS1—head and neck cancer	0.000326	0.0161	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000322	0.00126	CcSEcCtD
Venlafaxine—Dry mouth—Docetaxel—head and neck cancer	0.000322	0.00126	CcSEcCtD
Venlafaxine—Confusional state—Docetaxel—head and neck cancer	0.000319	0.00125	CcSEcCtD
Venlafaxine—Oedema—Docetaxel—head and neck cancer	0.000316	0.00124	CcSEcCtD
Venlafaxine—Anaphylactic shock—Docetaxel—head and neck cancer	0.000316	0.00124	CcSEcCtD
Venlafaxine—Infection—Docetaxel—head and neck cancer	0.000314	0.00123	CcSEcCtD
Venlafaxine—Shock—Docetaxel—head and neck cancer	0.000311	0.00122	CcSEcCtD
Venlafaxine—CYP2B6—Xenobiotics—CYP1A1—head and neck cancer	0.00031	0.0153	CbGpPWpGaD
Venlafaxine—Pruritus—Fluorouracil—head and neck cancer	0.00031	0.00121	CcSEcCtD
Venlafaxine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000309	0.00121	CcSEcCtD
Venlafaxine—Tachycardia—Docetaxel—head and neck cancer	0.000308	0.00121	CcSEcCtD
Venlafaxine—ABCG2—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.000302	0.0149	CbGpPWpGaD
Venlafaxine—Anorexia—Docetaxel—head and neck cancer	0.000301	0.00118	CcSEcCtD
Venlafaxine—Diarrhoea—Fluorouracil—head and neck cancer	0.000299	0.00117	CcSEcCtD
Venlafaxine—Hypotension—Docetaxel—head and neck cancer	0.000295	0.00116	CcSEcCtD
Venlafaxine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000292	0.0144	CbGpPWpGaD
Venlafaxine—Dizziness—Fluorouracil—head and neck cancer	0.000289	0.00113	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000288	0.00113	CcSEcCtD
Venlafaxine—Insomnia—Docetaxel—head and neck cancer	0.000286	0.00112	CcSEcCtD
Venlafaxine—Paraesthesia—Docetaxel—head and neck cancer	0.000284	0.00111	CcSEcCtD
Venlafaxine—Dyspnoea—Docetaxel—head and neck cancer	0.000282	0.0011	CcSEcCtD
Venlafaxine—Somnolence—Docetaxel—head and neck cancer	0.000281	0.0011	CcSEcCtD
Venlafaxine—Vomiting—Fluorouracil—head and neck cancer	0.000278	0.00109	CcSEcCtD
Venlafaxine—Dyspepsia—Docetaxel—head and neck cancer	0.000278	0.00109	CcSEcCtD
Venlafaxine—Rash—Fluorouracil—head and neck cancer	0.000276	0.00108	CcSEcCtD
Venlafaxine—Dermatitis—Fluorouracil—head and neck cancer	0.000276	0.00108	CcSEcCtD
Venlafaxine—Decreased appetite—Docetaxel—head and neck cancer	0.000275	0.00108	CcSEcCtD
Venlafaxine—Headache—Fluorouracil—head and neck cancer	0.000274	0.00107	CcSEcCtD
Venlafaxine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000273	0.0135	CbGpPWpGaD
Venlafaxine—Fatigue—Docetaxel—head and neck cancer	0.000272	0.00107	CcSEcCtD
Venlafaxine—Pain—Docetaxel—head and neck cancer	0.00027	0.00106	CcSEcCtD
Venlafaxine—Constipation—Docetaxel—head and neck cancer	0.00027	0.00106	CcSEcCtD
Venlafaxine—NPY1R—GPCR ligand binding—GRP—head and neck cancer	0.000269	0.0133	CbGpPWpGaD
Venlafaxine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000267	0.0132	CbGpPWpGaD
Venlafaxine—Feeling abnormal—Docetaxel—head and neck cancer	0.00026	0.00102	CcSEcCtD
Venlafaxine—Nausea—Fluorouracil—head and neck cancer	0.00026	0.00102	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000258	0.00101	CcSEcCtD
Venlafaxine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000257	0.0127	CbGpPWpGaD
Venlafaxine—Abdominal pain—Docetaxel—head and neck cancer	0.00025	0.000978	CcSEcCtD
Venlafaxine—Body temperature increased—Docetaxel—head and neck cancer	0.00025	0.000978	CcSEcCtD
Venlafaxine—CYP2C19—Xenobiotics—CYP1A1—head and neck cancer	0.000234	0.0116	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Docetaxel—head and neck cancer	0.000233	0.000911	CcSEcCtD
Venlafaxine—Asthenia—Docetaxel—head and neck cancer	0.000227	0.000887	CcSEcCtD
Venlafaxine—CYP2C19—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000225	0.0111	CbGpPWpGaD
Venlafaxine—Pruritus—Docetaxel—head and neck cancer	0.000224	0.000875	CcSEcCtD
Venlafaxine—SLC6A4—NRF2 pathway—TGFA—head and neck cancer	0.000223	0.011	CbGpPWpGaD
Venlafaxine—Diarrhoea—Docetaxel—head and neck cancer	0.000216	0.000846	CcSEcCtD
Venlafaxine—CYP2D6—Xenobiotics—CYP1A1—head and neck cancer	0.000215	0.0106	CbGpPWpGaD
Venlafaxine—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	0.000213	0.0105	CbGpPWpGaD
Venlafaxine—Dizziness—Docetaxel—head and neck cancer	0.000209	0.000818	CcSEcCtD
Venlafaxine—CYP2D6—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000207	0.0102	CbGpPWpGaD
Venlafaxine—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000205	0.0101	CbGpPWpGaD
Venlafaxine—Vomiting—Docetaxel—head and neck cancer	0.000201	0.000786	CcSEcCtD
Venlafaxine—Rash—Docetaxel—head and neck cancer	0.000199	0.00078	CcSEcCtD
Venlafaxine—Dermatitis—Docetaxel—head and neck cancer	0.000199	0.000779	CcSEcCtD
Venlafaxine—Headache—Docetaxel—head and neck cancer	0.000198	0.000775	CcSEcCtD
Venlafaxine—SLC6A2—NRF2 pathway—TGFA—head and neck cancer	0.000192	0.00948	CbGpPWpGaD
Venlafaxine—Nausea—Docetaxel—head and neck cancer	0.000188	0.000735	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—KISS1—head and neck cancer	0.000184	0.0091	CbGpPWpGaD
Venlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00018	0.00887	CbGpPWpGaD
Venlafaxine—CYP2C19—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000174	0.00858	CbGpPWpGaD
Venlafaxine—SLC6A3—NRF2 pathway—TGFA—head and neck cancer	0.00017	0.0084	CbGpPWpGaD
Venlafaxine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000168	0.0083	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—KISS1—head and neck cancer	0.000167	0.00826	CbGpPWpGaD
Venlafaxine—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000162	0.00797	CbGpPWpGaD
Venlafaxine—CYP2D6—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.00016	0.00789	CbGpPWpGaD
Venlafaxine—SLC6A3—Dopaminergic Neurogenesis—STAT3—head and neck cancer	0.000154	0.00761	CbGpPWpGaD
Venlafaxine—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000153	0.00756	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—GRP—head and neck cancer	0.000152	0.00749	CbGpPWpGaD
Venlafaxine—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000141	0.00695	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—GRP—head and neck cancer	0.000138	0.0068	CbGpPWpGaD
Venlafaxine—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000135	0.00668	CbGpPWpGaD
Venlafaxine—SLC6A4—NRF2 pathway—GSTM1—head and neck cancer	0.00013	0.0064	CbGpPWpGaD
Venlafaxine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—head and neck cancer	0.000129	0.00639	CbGpPWpGaD
Venlafaxine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000129	0.00635	CbGpPWpGaD
Venlafaxine—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000127	0.00626	CbGpPWpGaD
Venlafaxine—CYP2B6—Biological oxidations—NAT2—head and neck cancer	0.000118	0.00584	CbGpPWpGaD
Venlafaxine—CYP2B6—Metapathway biotransformation—NAT2—head and neck cancer	0.000117	0.00576	CbGpPWpGaD
Venlafaxine—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000114	0.00561	CbGpPWpGaD
Venlafaxine—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000112	0.00555	CbGpPWpGaD
Venlafaxine—SLC6A2—NRF2 pathway—GSTM1—head and neck cancer	0.000112	0.00551	CbGpPWpGaD
Venlafaxine—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000104	0.00515	CbGpPWpGaD
Venlafaxine—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000104	0.00511	CbGpPWpGaD
Venlafaxine—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000103	0.00506	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—TYMS—head and neck cancer	0.000102	0.00502	CbGpPWpGaD
Venlafaxine—ABCG2—Fluoropyrimidine Activity—TP53—head and neck cancer	0.0001	0.00494	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—KISS1—head and neck cancer	9.89e-05	0.00488	CbGpPWpGaD
Venlafaxine—SLC6A3—NRF2 pathway—GSTM1—head and neck cancer	9.88e-05	0.00488	CbGpPWpGaD
Venlafaxine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	9.72e-05	0.0048	CbGpPWpGaD
Venlafaxine—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	9.59e-05	0.00473	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	9.15e-05	0.00452	CbGpPWpGaD
Venlafaxine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	8.94e-05	0.00441	CbGpPWpGaD
Venlafaxine—CYP2C19—Biological oxidations—NAT2—head and neck cancer	8.94e-05	0.00441	CbGpPWpGaD
Venlafaxine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	8.86e-05	0.00437	CbGpPWpGaD
Venlafaxine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	8.82e-05	0.00435	CbGpPWpGaD
Venlafaxine—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	8.81e-05	0.00435	CbGpPWpGaD
Venlafaxine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	8.74e-05	0.00432	CbGpPWpGaD
Venlafaxine—CYP2D6—Biological oxidations—NAT2—head and neck cancer	8.22e-05	0.00406	CbGpPWpGaD
Venlafaxine—CYP2C9—Biological oxidations—NAT2—head and neck cancer	8.15e-05	0.00402	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—GRP—head and neck cancer	8.14e-05	0.00402	CbGpPWpGaD
Venlafaxine—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	8.11e-05	0.004	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—ATP7B—head and neck cancer	8.11e-05	0.004	CbGpPWpGaD
Venlafaxine—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	8.04e-05	0.00397	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—STAT6—head and neck cancer	7.9e-05	0.0039	CbGpPWpGaD
Venlafaxine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	7.88e-05	0.00389	CbGpPWpGaD
Venlafaxine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	7.61e-05	0.00376	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	7.45e-05	0.00368	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	7.34e-05	0.00362	CbGpPWpGaD
Venlafaxine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	7.25e-05	0.00358	CbGpPWpGaD
Venlafaxine—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	7.23e-05	0.00357	CbGpPWpGaD
Venlafaxine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	7.18e-05	0.00355	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—YAP1—head and neck cancer	6.99e-05	0.00345	CbGpPWpGaD
Venlafaxine—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	6.69e-05	0.0033	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	6.67e-05	0.00329	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—UROD—head and neck cancer	6.64e-05	0.00328	CbGpPWpGaD
Venlafaxine—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	6.1e-05	0.00301	CbGpPWpGaD
Venlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	5.84e-05	0.00288	CbGpPWpGaD
Venlafaxine—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	5.84e-05	0.00288	CbGpPWpGaD
Venlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	5.77e-05	0.00285	CbGpPWpGaD
Venlafaxine—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	5.76e-05	0.00284	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—CASP8—head and neck cancer	5.55e-05	0.00274	CbGpPWpGaD
Venlafaxine—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	5.54e-05	0.00273	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	5.46e-05	0.0027	CbGpPWpGaD
Venlafaxine—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	5.46e-05	0.0027	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—NAT2—head and neck cancer	5.37e-05	0.00265	CbGpPWpGaD
Venlafaxine—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	5.3e-05	0.00262	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—PTEN—head and neck cancer	4.94e-05	0.00244	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—UROD—head and neck cancer	4.87e-05	0.0024	CbGpPWpGaD
Venlafaxine—ABCG2—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	4.86e-05	0.0024	CbGpPWpGaD
Venlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	4.74e-05	0.00234	CbGpPWpGaD
Venlafaxine—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	4.41e-05	0.00218	CbGpPWpGaD
Venlafaxine—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	4.35e-05	0.00215	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—IL2—head and neck cancer	4.2e-05	0.00207	CbGpPWpGaD
Venlafaxine—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	4.18e-05	0.00207	CbGpPWpGaD
Venlafaxine—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	4.13e-05	0.00204	CbGpPWpGaD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	4.12e-05	0.00203	CbGpPWpGaD
Venlafaxine—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	4.06e-05	0.002	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—IL2—head and neck cancer	4.04e-05	0.002	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	4.03e-05	0.00199	CbGpPWpGaD
Venlafaxine—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	4.02e-05	0.00199	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	4.01e-05	0.00198	CbGpPWpGaD
Venlafaxine—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	4e-05	0.00198	CbGpPWpGaD
Venlafaxine—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	3.97e-05	0.00196	CbGpPWpGaD
Venlafaxine—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	3.85e-05	0.0019	CbGpPWpGaD
Venlafaxine—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	3.82e-05	0.00188	CbGpPWpGaD
Venlafaxine—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	3.8e-05	0.00187	CbGpPWpGaD
Venlafaxine—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	3.76e-05	0.00186	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—UROD—head and neck cancer	3.68e-05	0.00182	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—IL2—head and neck cancer	3.67e-05	0.00181	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—UROD—head and neck cancer	3.59e-05	0.00177	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	3.57e-05	0.00176	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—UROD—head and neck cancer	3.39e-05	0.00167	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—TP53—head and neck cancer	3.37e-05	0.00166	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—UROD—head and neck cancer	3.36e-05	0.00166	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—NOTCH1—head and neck cancer	3.15e-05	0.00156	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—MAPK1—head and neck cancer	3.07e-05	0.00152	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—MAPK3—head and neck cancer	2.95e-05	0.00146	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.86e-05	0.00141	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—MAPK1—head and neck cancer	2.81e-05	0.00139	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—EGFR—head and neck cancer	2.81e-05	0.00139	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—NAT2—head and neck cancer	2.76e-05	0.00136	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	2.74e-05	0.00135	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—PIK3CA—head and neck cancer	2.68e-05	0.00132	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	2.65e-05	0.00131	CbGpPWpGaD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	2.63e-05	0.0013	CbGpPWpGaD
Venlafaxine—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	2.62e-05	0.00129	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.6e-05	0.00129	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	2.52e-05	0.00124	CbGpPWpGaD
Venlafaxine—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	2.48e-05	0.00122	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—HRAS—head and neck cancer	2.47e-05	0.00122	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—PIK3CA—head and neck cancer	2.44e-05	0.0012	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—DPYD—head and neck cancer	2.42e-05	0.00119	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—MAPK1—head and neck cancer	2.35e-05	0.00116	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	2.35e-05	0.00116	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—YAP1—head and neck cancer	2.3e-05	0.00113	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—HRAS—head and neck cancer	2.26e-05	0.00111	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	2.23e-05	0.0011	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—UROD—head and neck cancer	2.21e-05	0.00109	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—AKT1—head and neck cancer	2.19e-05	0.00108	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—IL2—head and neck cancer	2.17e-05	0.00107	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CCND1—head and neck cancer	2.11e-05	0.00104	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PTEN—head and neck cancer	2.04e-05	0.00101	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—NAT2—head and neck cancer	2.02e-05	0.000998	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	2.02e-05	0.000996	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—AKT1—head and neck cancer	1.99e-05	0.000983	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	1.95e-05	0.000961	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—HRAS—head and neck cancer	1.89e-05	0.000932	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—VEGFA—head and neck cancer	1.84e-05	0.00091	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—STAT3—head and neck cancer	1.83e-05	0.000901	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—DPYD—head and neck cancer	1.77e-05	0.000875	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	1.76e-05	0.000868	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MAPK3—head and neck cancer	1.74e-05	0.000861	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—YAP1—head and neck cancer	1.68e-05	0.000831	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	1.66e-05	0.000821	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MAPK1—head and neck cancer	1.66e-05	0.000819	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—EGFR—head and neck cancer	1.66e-05	0.000819	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.62e-05	0.000801	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.61e-05	0.000793	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.58e-05	0.000782	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.58e-05	0.000781	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—NAT2—head and neck cancer	1.53e-05	0.000754	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—NAT2—head and neck cancer	1.49e-05	0.000736	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.48e-05	0.000731	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.47e-05	0.000723	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PIK3CA—head and neck cancer	1.44e-05	0.000711	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—NAT2—head and neck cancer	1.41e-05	0.000694	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—NAT2—head and neck cancer	1.39e-05	0.000688	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TP53—head and neck cancer	1.39e-05	0.000688	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—TYMS—head and neck cancer	1.38e-05	0.00068	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.37e-05	0.000678	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GSTM1—head and neck cancer	1.36e-05	0.000673	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—DPYD—head and neck cancer	1.34e-05	0.000661	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—HRAS—head and neck cancer	1.33e-05	0.000658	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.33e-05	0.000656	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—DPYD—head and neck cancer	1.31e-05	0.000646	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GPX1—head and neck cancer	1.31e-05	0.000644	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CYP1A1—head and neck cancer	1.29e-05	0.000638	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—YAP1—head and neck cancer	1.27e-05	0.000628	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—YAP1—head and neck cancer	1.24e-05	0.000613	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—DPYD—head and neck cancer	1.23e-05	0.000608	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—DPYD—head and neck cancer	1.22e-05	0.000603	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—AKT1—head and neck cancer	1.18e-05	0.000581	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—YAP1—head and neck cancer	1.17e-05	0.000577	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—YAP1—head and neck cancer	1.16e-05	0.000572	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.12e-05	0.000554	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—TYMS—head and neck cancer	1.01e-05	0.000499	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GSTM1—head and neck cancer	9.99e-06	0.000493	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GPX1—head and neck cancer	9.57e-06	0.000472	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	9.56e-06	0.000472	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CYP1A1—head and neck cancer	9.47e-06	0.000467	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—NAT2—head and neck cancer	9.19e-06	0.000454	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	8.71e-06	0.00043	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	8.33e-06	0.000411	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—DPYD—head and neck cancer	8.06e-06	0.000398	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PTGS2—head and neck cancer	7.68e-06	0.000379	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—YAP1—head and neck cancer	7.65e-06	0.000377	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—TYMS—head and neck cancer	7.64e-06	0.000377	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.6e-06	0.000375	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GSTM1—head and neck cancer	7.55e-06	0.000373	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—TYMS—head and neck cancer	7.45e-06	0.000368	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GSTM1—head and neck cancer	7.37e-06	0.000364	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GPX1—head and neck cancer	7.23e-06	0.000357	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CYP1A1—head and neck cancer	7.16e-06	0.000353	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GPX1—head and neck cancer	7.06e-06	0.000348	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—TYMS—head and neck cancer	7.02e-06	0.000347	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CYP1A1—head and neck cancer	6.98e-06	0.000345	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—TYMS—head and neck cancer	6.96e-06	0.000344	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GSTM1—head and neck cancer	6.94e-06	0.000343	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GSTM1—head and neck cancer	6.88e-06	0.00034	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PTEN—head and neck cancer	6.7e-06	0.000331	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GPX1—head and neck cancer	6.65e-06	0.000328	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GPX1—head and neck cancer	6.59e-06	0.000325	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CYP1A1—head and neck cancer	6.58e-06	0.000325	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CYP1A1—head and neck cancer	6.53e-06	0.000322	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.88e-06	0.00029	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PTGS2—head and neck cancer	5.63e-06	0.000278	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.36e-06	0.000265	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PTEN—head and neck cancer	4.91e-06	0.000242	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PIK3CA—head and neck cancer	4.73e-06	0.000233	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—TYMS—head and neck cancer	4.59e-06	0.000227	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GSTM1—head and neck cancer	4.54e-06	0.000224	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GPX1—head and neck cancer	4.35e-06	0.000215	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	4.3e-06	0.000212	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PTGS2—head and neck cancer	4.26e-06	0.00021	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PTGS2—head and neck cancer	4.15e-06	0.000205	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PTGS2—head and neck cancer	3.91e-06	0.000193	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PTGS2—head and neck cancer	3.88e-06	0.000192	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—AKT1—head and neck cancer	3.86e-06	0.000191	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PTEN—head and neck cancer	3.71e-06	0.000183	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PTEN—head and neck cancer	3.62e-06	0.000179	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PIK3CA—head and neck cancer	3.46e-06	0.000171	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PTEN—head and neck cancer	3.41e-06	0.000168	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PTEN—head and neck cancer	3.38e-06	0.000167	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—AKT1—head and neck cancer	2.83e-06	0.00014	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PIK3CA—head and neck cancer	2.62e-06	0.000129	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PTGS2—head and neck cancer	2.56e-06	0.000126	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PIK3CA—head and neck cancer	2.56e-06	0.000126	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	2.41e-06	0.000119	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PIK3CA—head and neck cancer	2.39e-06	0.000118	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PTEN—head and neck cancer	2.23e-06	0.00011	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—AKT1—head and neck cancer	2.14e-06	0.000106	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—AKT1—head and neck cancer	2.09e-06	0.000103	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—AKT1—head and neck cancer	1.97e-06	9.71e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—AKT1—head and neck cancer	1.95e-06	9.63e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.57e-06	7.77e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—AKT1—head and neck cancer	1.29e-06	6.35e-05	CbGpPWpGaD
